Lucy Carty
Impact in
- Developmental Neuroscience top 10%
- Neurogenesis and neuroplasticity mechanisms
-
- Nerve injury and regeneration
- Hereditary Neurological Disorders
- Genetic Neurodegenerative Diseases
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Nerve injury and regeneration 2
- Hereditary Neurological Disorders 2
- Genetic Neurodegenerative Diseases 1
- Co-authors
- Shivani Padmanabhan (2 shared papers)Helen Strongman (2 shared papers)Rachael Williams (2 shared papers)Rebecca Ghosh (1 shared paper)Ellen Cameron (1 shared paper)Ralph André (1 shared paper)Sarah J. Tabrizi (1 shared paper)Rhona Mirsky (2 shared papers)
- Journals
- Pharmacoepidemiology and Drug Safety (2 papers)BMJ Open (2 papers)British Journal of General Practice (1 paper)European Journal of Public Health (1 paper)Journal of Infection (1 paper)
- Partner nations
- United KingdomSwedenSwitzerland
In The Last Decade
Lucy Carty
10 papers receiving 403 citations
Lucy Carty's Hit Papers
Peers
Comparison fields: 5 of 76
- Developmental Neuroscience 35
- Cellular and Molecular Neuroscience 115
- Neurology 46
- Infectious Diseases 54
- Family Practice 3
Countries citing papers authored by Lucy Carty
This map shows the geographic impact of Lucy Carty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Carty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Carty more than expected).
Fields of papers citing papers by Lucy Carty
This network shows the impact of papers produced by Lucy Carty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Carty. The network helps show where Lucy Carty may publish in the future.
Co-authors
The 25 scholars most cited alongside Lucy Carty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 151 | |
| 2 | Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study Hit paper breakdown → | 2023 | 95 |
| 3 | 2014 | 59 | |
| 4 | 2011 | 51 | |
| 5 | 2015 | 38 | |
| 6 | 2019 | 10 | |
| 7 | 2019 | 4 | |
| 8 | 2025 | 2 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2025 | 0 | |
| 12 | 2025 | 0 | |
| 13 | 2024 | 0 |
About Lucy Carty
Lucy Carty is a scholar working on Infectious Diseases, Cellular and Molecular Neuroscience, Neurology, Epidemiology and Molecular Biology, having authored 13 papers that have together received 412 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Nerve injury and regeneration (2 papers), Peripheral Neuropathies and Disorders (2 papers), Hereditary Neurological Disorders (2 papers), Vaccine Coverage and Hesitancy (1 paper), Patient Satisfaction in Healthcare (1 paper), Mitochondrial Function and Pathology (1 paper) and Genetic Neurodegenerative Diseases (1 paper). The work is most often cited by research in Developmental Neuroscience (35 citations), Cellular and Molecular Neuroscience (115 citations), Neurology (46 citations), Infectious Diseases (54 citations) and Family Practice (3 citations). Lucy Carty has collaborated with scholars based in United Kingdom, Sweden and Switzerland. Frequent co-authors include Shivani Padmanabhan, Helen Strongman, Rachael Williams, Rebecca Ghosh, Ellen Cameron, Ralph André, Sarah J. Tabrizi, Rhona Mirsky, Kristján R. Jessen and Elspeth Hutton. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, BMJ Open, British Journal of General Practice, European Journal of Public Health and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.